Leonore

Ethinylestradiol and Levonorgestrel, the active ingredients in Leonore, are a combined oral contraceptive presented as a tablet for oral use. They work together to prevent pregnancy in women of reproductive age by inhibiting ovulation, thickening cervical mucus, and modifying the endometrium, providing reliable hormonal birth control.

GNH USA supplies Leonore as a licensed, GDP‑compliant international pharmaceutical supplier, delivering the product to hospitals, pharmacies and clinics worldwide with adherence to quality standards and regulatory requirements.

Leonore, a combined oral contraceptive, acts on the hormonal regulation pathway to prevent pregnancy. - Contraception: prevention of pregnancy in women of reproductive age. - Menstrual cycle regulation: helps achieve more regular and predictable periods. - Acne improvement: may reduce hormonal acne associated with menstrual cycles.

Leonore may cause a range of adverse reactions, which are generally classified by frequency and severity.

Common Side Effects: - Nausea: mild stomach upset. - Headache: tension‑type or migraine‑like pain. - Breast tenderness: soreness or swelling. - Irregular bleeding: spotting or breakthrough bleeding.

Serious or Rare Side Effects: - Deep vein thrombosis: clot formation in deep veins. - Pulmonary embolism: clot traveling to lungs. - Severe allergic reaction: rash, swelling, difficulty breathing.

Before prescribing Leonore, several precautions should be considered to ensure safe use. - Contraindication: avoid in women with known thromboembolic disorders. - Smoking: do not use if over 35 years and a smoker. - Cardiovascular risk: assess history of hypertension, stroke, or myocardial infarction. - Liver disease: use with caution in patients with active liver disease. - Pregnancy: contraindicated; pregnancy must be ruled out before initiation. - Store at ambient temperature: keep below 25 °C in the original packaging, protect from moisture and light.

Leonore can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Anticoagulants: may reduce effectiveness of warfarin, requiring monitoring. - Antiepileptic enzyme inducers (e.g., carbamazepine, phenytoin): can lower contraceptive hormone levels, increasing pregnancy risk. - Certain antibiotics (e.g., rifampicin): may decrease hormonal concentrations.

Moderate Interactions (Monitor Closely): - Antifungals (e.g., ketoconazole): may increase hormone levels, raising side‑effect risk. - St. John’s wort: may reduce contraceptive effectiveness. - Selective serotonin reuptake inhibitors (SSRIs): may increase risk of mood changes.